Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-25T18:51:03.706Z Has data issue: false hasContentIssue false

15 The Role of Race and Adverse Childhood Experiences on Predicting Cognitive Ability on the Montreal Cognitive Assessment (MoCA).

Published online by Cambridge University Press:  21 December 2023

Veronica Koralewski*
Affiliation:
University of Illinois, Chicago, Illinois, USA. Point Loma Nazarene University, San Diego, California, USA
Matthew S. Phillips
Affiliation:
University of Illinois, Chicago, Illinois, USA.
Ayesha Arora
Affiliation:
University of Illinois, Chicago, Illinois, USA.
Woojin Song
Affiliation:
University of Illinois, Chicago, Illinois, USA.
Neil Pliskin
Affiliation:
University of Illinois, Chicago, Illinois, USA.
Jason R. Soble
Affiliation:
University of Illinois, Chicago, Illinois, USA.
Zachary J. Resch
Affiliation:
University of Illinois, Chicago, Illinois, USA.
Kyle Jennette
Affiliation:
University of Illinois, Chicago, Illinois, USA.
*
Correspondence: Veronica Koralewski, University of Illinois at Chicago, Point Loma Nazarene University, [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

Awareness of risk factors associated with any form of impairment is critical for formulating optimal prevention and treatment planning. Millions worldwide suffer from some form of cognitive impairment, with the highest rates amongst Black and Hispanic populations. The latter have also been found to achieve lower scores on standardized neurocognitive testing than other racial/ethnic groups. Understanding the socio-demographic risk factors that lead to this discrepancy in neurocognitive functioning across racial groups is crucial. Adverse childhood experiences (ACEs), are one aspect of social determinants of health. ACES have been linked to a greater risk of future memory impairment, such as dementia. Moreover, higher instances of ACEs have been found amongst racial minorities. Considering the current literature, the purpose of this exploratory research is to better understand how social determinants, more specifically, ACEs, may play a role in the development of cognitive impairment.

Participants and Methods:

This cross-sectional study included data from an urban, public Midwestern academic medical center. There was a total of 64 adult clinical patients that were referred for a neuropsychological evaluation. All patients were administered a standardized neurocognitive battery that included the Montreal Cognitive Assessment (MoCA) as well as a 10-item ACE questionnaire, which measures levels of adverse childhood experiences. The sample was 73% Black and 27% White. The average age was 66 (SD=8.6) and average education was 12.6 years (SD=3.4). A two-way ANOVA was conducted to evaluate the interaction of racial identity (White; Black) and ACE score on MoCA total score. An ACE score >4 was categorized as “high”; ACE <4 was categorized as “low.”

Results:

There was not a significant interaction of race and ACE group on MoCA score (p=.929) nor a significant main effect of ACE score (p=.541). Interestingly, there was a significant main effect of Race on MoCA (p=.029). White patients had an average MoCA score of 21.82 (sd=4.77). Black patients had an average MoCA score of 17.54 (sd=5.91).

Conclusions:

Overall, Black patients demonstrated statistically lower scores on the MoCA than White patients. There was no significant difference on MoCA score between races when also accounting for ACE scores. Given this study’s findings, one’s level of adverse childhood experiences does not appear to impact one’s cognitive ability later in life. There is a significant difference in cognitive ability between races, specifically Black and White people, which suggests there may be social determinants other than childhood experiences to be explored that influence cognitive impairment.

Type
Poster Session 01: Medical | Neurological Disorders | Neuropsychiatry | Psychopharmacology
Copyright
Copyright © INS. Published by Cambridge University Press, 2023